Renan Ozyerli, MD, MSD Turkey
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD works hand-in-hand with the government to broaden access to…
Address: Yildiz Posta Caddesi, Is Bankası Bloklari B Blok Da: 1; 34349 Esentepe / ISTANBUL,Turkey
Tel: +90 (212) 275 96 30
TISD was founded in 1951 in Istanbul, and consist of companies that are all established in Turkey. Currently, TISD has 27 members.
GOALS OF THE ASSOCIATION
• To help Turkish drug manufacturing industry to improve and progress.
• To make professional, technical, and commercial correlations and collaborations (when necessary) among its members, prevent unfair competition, fix conflicts.
• To supply any kind of matters and materials that are dedicated to and needed to be imported on behalf of members of the association, distribute them fairly, and in this regards, represent its members at official departments to contact and conclude issues, prepare necessary printed documents.
• To run the tasks that including drug and drug raw material with its collateral material, manufacturing and improvement of materials, helping to have a license and authorization.
• To accommodate drug prices to have a system that provides industry to improve, adapts to country’s economy, works spontaneously, and is permanent and fair.
• To do all the necessary works at any level for pricing issue
• To participate to decisions
• To be beneficial to its members
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD works hand-in-hand with the government to broaden access to…
Raphaël Esposito, director of the French Chamber of Commerce in Turkey, sheds light on issues ranging from venture partnerships to cultural specificities, while underlining Turkey’s capacity to respond to the…
Asli Özelli, newly appointed executive director of AmCham Turkey, discusses the economic landscape of Turkey and its attractiveness for American companies, in addition to highlighting her priorities in her new…
Hande Demirdere, general manager of Pierre Fabre Pharma in Turkey, sheds light on the affiliate’s impressive 93 percent growth in 2017 while highlighting where to target development opportunities in the…
Selim Giray, the recently appointed VP and general manager of GSK Turkey, provides insights into the company’s eye-catching footprint and commitment to Turkey, his ambition to integrate into the market’s…
In Summer 2018, we spoke to Adriano Antonio Treve, then general manager of Roche Turkey, now Area Head Central Eastern Europe, Turkey, Russia, Central Asia, Iran, Pakistan & Indian Subcontinent.…
Elif Aral, country manager of Pfizer Turkey, stresses that Turkey will continue to be perceived as essential and important, where healthcare is a top priority with its young but aging…
Mustafa Kemal Erol , president of the Turkish Society of Cardiology, introduces one of the oldest and largest societies in the country divulges their best collaborations with the Ministry of…
Abdi İbrahim Otsuka, the Turkish-Japanese hybrid pharmaceutical company, celebrated their five-year anniversary just last year and have ambitions to become the Number One Japanese company in Turkey. Elif Elkin, in…
Mark Dekker, general manager of Astellas in Turkey, describes the ever-increasing commitment of the company to Turkey and the recent doubling of Astellas’ portfolio in the country, while pinpointing the…
Mahmut Gümüş, president of the Turkish Society of Medical Oncology, paints a descriptive picture of the oncology situation in the country, with the looming epidemiological shift set to transform the…
Hakan Koçak, CEO–general manager of Koçak Farma, a company with 47 years in the pharmaceutical industry and the biggest production facility in Turkey, gives a thorough insight into Koçak Farma’s…
See our Cookie Privacy Policy Here
